Showing results (991-1000 of 3,016) with videos related to
Sort By:
Pageof 302
Current Drug Targets|February 22, 2005
Small interfering RNAs and antisense oligonucleotides for treatment of neurological diseasesA Forte, M Cipollaro, A Cascino, et al.Current Drug Targets|February 22, 2005
Neuropathic pain: is the end of suffering starting in the gene therapy?D Siniscalco, V de Novellis, F Rossi, et al.Current Drug Targets|February 22, 2005
Adult neural stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantationJ Zhu, X Wu, H L ZhangCurrent Drug Targets|December 8, 2004
Progress in thioaptamer developmentXianbin Yang, David G GorensteinCurrent Drug Targets|December 8, 2004
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expressionM Borgatti, A Finotti, A Romanelli, et al.Current Drug Targets|December 8, 2004
Locked nucleic acids (LNA): versatile tools for designing oligonucleotide decoys with high stability and affinityR Crinelli, M Bianchi, L Gentilini, et al.Current Drug Targets|July 24, 2004
Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathiesK Iqbal, I Grundke-IqbalCurrent Drug Targets|July 24, 2004
Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animalsFeng Chen, Della David, Alessandra Ferrari, et al.Current Drug Targets|March 22, 2005
Peptide YY: a potential therapy for obesityD Renshaw, R L BatterhamPageof 302